You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
TLR Signal Inhibition: A Novel Therapeutic Paradigm
SBC: INTERTHYR CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Interthyr Corporation (IC) is requesting an Advanced Technology Phase II STTR award to develop a novel agent with a new therapeutic paradigm: Inhibition of Toll-like receptor (TLR) expression and signaling in non-immune cells. In pursuing studies based on its Phase I award, IC has shown that a lead compound from a family of tautomeric cyclic thiones (TCTs), phe ...
STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health -
Endothelialized microfluidic assays for emerging therapies in sickle cell disease
SBC: BIOCHIP LABS, INC. Topic: NHLBITBD
STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
SciDAP: Scientific Data Analysis Platform
SBC: DATIRIUM LLC Topic: NHGRIThe recent proliferation of next-generation sequencing (NGS) - based methods for the analysis of expression, chromatin and protein-DNA interactions has created tremendous opportunities for gaining insights into biology, health, and disease. However, analysis of the data requires computational expertise that many biologists do not possess. Hence, when dealing with genomics data, majority of biologi ...
STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Testing and Commercialization of a Superior Device to Maintain Perioperative Normothermia In Anesthetized Patients
SBC: Mercury Biomed LLC Topic: 300Project SummaryAbstractThis proposal presents Phase II of Mercury Biomedandapos s plan for commercializing the new and innovative WarmSmart technology to more effectively keep surgical patients normothermicWarmSmart embodies several breakthrough concepts in bioheat transfer to manage core temperatureWe are building a costcompetitive patient warming technology that will be superior to existing tech ...
STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Tissue Engineered Intestine
SBC: NANOFIBER SOLUTIONS LLC Topic: 300PROJECT ABSTRACT Short bowel syndromeSBSis a major clinical problem affecting newbornschildren and adultsfor which there is currently no known cureThe disorder results from the functional or anatomic loss of extensive segments of small intestine rendering the intestinal absorptive capacity severely compromisedSBS is clinically defined by malabsorptiondiarrheasteatorrheafluid and electrolyte distur ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Making Standing Balance The Fifth Vital Sign in Clinical Settings
SBC: BERTEC CORP Topic: NIAFalls are a significant source of early morbidity and mortality in the aging population, yet the neurological,sensory, and motor changes that lead to increased fall risk often escape early identification and intervention. Vital signs are commonly used in clinical settings to assess the cardiovascular system (blood pressure, heart rate), immune system (body temperature), and the respiratory system ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Whisper Next Generation
SBC: ASYMMETRIC TECHNOLOGIES, LLC Topic: SOCOM22DST01Asymmetric proposes to develop software and firmware to optimize data exfil throughout Whisper devices. This includes making the Whisper system have additional, tuneable capabilities to increase LPI/LPD characteristics. The current methods utilized by Special Operations Forces (SOF) personnel to maintain secure, covert and reliable data transmission in hostile environments is difficult and mission ...
STTR Phase II 2023 Department of DefenseSpecial Operations Command -
Marrow-Derived Stem Cells for Coronary Artery Ischemia
SBC: Arteriocyte, Inc. Topic: N/ADESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of morbidity and mortality in the United States, accounting for approximately 1 million deaths per year. The objective of the Phase I pre-clinical studies outlined in this fasttrack STTR proposal is to validate the proposed methods of isolation, characterization, and administration of preferred progenitor cell prepar ...
STTR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
Compatibility between Brain-Computer Interface and High-Efficiency Augmentative and Alternative Communication Systems
SBC: Prentke Romich Company Topic: NIDCDCompatibility between Brain-Computer Interface and High Efficiency Augmentative and AlternativeCommunication Systems: Phase II ABSTRACT Brain-computer interfaces (BCI) enable text production for people who cannot move, but have only simple communication interfaces and are not widely used. Augmentative and alternative communication (AAC) systems are widely used and give efficient and precise commun ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Whole Mouse Cryo-Imaging
SBC: BIOINVISION INC Topic: N/ADESCRIPTION (provided by applicant): BioInVision, Inc. and Case Western Reserve University researchers will develop a cryo-imaging system for 3D imaging of mice. It will serve very many applications in biological research and the biotechnology industry, in cluding mouse anatomical phenotyping, drug delivery, imaging agents, metastastic cancer, pathogen/immune system response, and stem cells/regene ...
STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health